Key facts
- This page summarizes Medicxi Ventures Management (Jersey) Ltd's Form 3 filing for Phathom Pharmaceuticals, Inc. (PHAT).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 26 Jan 2024, 16:35.
Medicxi Ventures Management (Jersey) Ltd - 24 Jan 2024 Form 3 Insider Report for Phathom Pharmaceuticals, Inc. (PHAT)
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- PHAT
- Reported as of
- 24 Jan 2024
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 26 Jan 2024, 16:35:59 UTC
- Prior SEC filing
- 23 Mar 2022
- Next SEC filing
- 06 Jan 2025
- Source filing
- View source filing
- Reporting owner signature
- MEDICXI VENTURES MANAGEMENT (JERSEY) LIMITED, By: /s/ Giles Johnstone-Scott, Director
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Medicxi Ventures Management (Jersey) Ltd filed Form 3 for Phathom Pharmaceuticals, Inc. (PHAT) on 26 Jan 2024.
Change
- Previous filing in this sequence was filed on 23 Mar 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
PHAT
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 3,673,602
- Date
- 24 Jan 2024
- Ownership
- By Medicxi Growth I LP
- Footnotes
- F1
PHAT
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 87,267
- Date
- 24 Jan 2024
- Ownership
- By Medicxi Growth Co-Invest I LP
- Footnotes
- F2
PHAT
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 3,641,728
- Date
- 24 Jan 2024
- Ownership
- By Medicxi IV LP
- Footnotes
- F3
PHAT
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 61,975
- Date
- 24 Jan 2024
- Ownership
- By Medicxi Co-Invest IV LP
- Footnotes
- F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
Shares held by Medicxi Growth I LP ("Growth I"). Medicxi Growth I GP Limited ("Growth I GP") is the sole general partner of Growth I, and Medicxi Ventures Management (Jersey) Limited ("Medicxi Manager") is the sole manager of Growth I. The Reporting Persons disclaim Section 16 beneficial ownership of the securities held by Growth I, except to the extent of their respective pecuniary interest therein, if any, and this report shall not be deemed to be an admission that they are the beneficial owners of such shares for Section 16 or any other purpose.
Footnote F2
Shares held by Medicxi Growth Co-Invest I LP ("Growth Co-Invest I"). Growth I GP is the sole general partner of Growth Co-Invest I, and Medicxi Manager is the sole manager of Growth Co-Invest I. The Reporting Persons disclaim Section 16 beneficial ownership of the securities held by Growth Co-Invest I, except to the extent of their respective pecuniary interest therein, if any, and this report shall not be deemed to be an admission that they are the beneficial owners of such shares for Section 16 or any other purpose.
Footnote F3
Shares held Medicxi IV LP ("Medicxi IV"). Medicxi IV GP Limited ("Medicxi IV GP") is the sole general partner of Medicxi IV, and Medicxi Manager is the sole manager of Medicxi IV. The Reporting Persons disclaim Section 16 beneficial ownership of the securities held by Medicxi IV, except to the extent of their respective pecuniary interest therein, if any, and this report shall not be deemed to be an admission that they are the beneficial owners of such shares for Section 16 or any other purpose.
Footnote F4
Shares held by Medicxi Co-Invest IV LP ("Co-Invest IV"). Medicxi IV GP is the sole general partner of Co-Invest IV, and Medicxi Manager is the sole manager of Co-Invest IV. The Reporting Persons disclaim Section 16 beneficial ownership of the securities held by Co-Invest IV, except to the extent of their respective pecuniary interest therein, if any, and this report shall not be deemed to be an admission that they are the beneficial owners of such shares for Section 16 or any other purpose.